Fakhrul said that he would give updates on her health time to time.
One of Khaleda’s personal physicians told New Age that the BNP chairperson’s personal staff, Fatema Begum, guards and some other members at her Gulshan residence Firoza also tested positive for COVID-19 in the past few days.
Khaleda has been staying at the Gulshan residence since she was released from jail by the government on conditions for six months on an executive order on March 25, 2020 during the novel coronavirus outbreak.
She was initially jailed on February 8, 2018 for five years in the Zia Orphanage Trust graft case.
Daily deaths rise to 77, getting ICU bed becomes matter of luck
Manzur H Maswood | Published: 00:30, Apr 11,2021 | Updated: 00:52, Apr 11,2021
It has become a matter of great luck for critical COVID-19 patients to get an ICU bed at a government hospital as the health system has been facing an overwhelming pressure due to the rising influx of coronavirus patients.
Critical COVID-19 patients in need of ICU support are shuttling from hospital to hospital in vain while few fortunate ones with high-level connections obtain the facility.
As the capital has the concentration of COVID-19 patients, the availability of ICU beds has severely shrunk in Bangladesh’s capital Dhaka.
BSEC plans to delist 8 more OTC cos under exit scheme
25 cos to be sent to alterative trading board, 15 others to SME platform
Mostafizur Rahman | Published: 22:49, Apr 03,2021
A file photo shows the front view of Bangladesh Securities and Exchange Commission building in the capital. The Bangladesh Securities and Exchange Commission has moved to delist eight more companies trading on the over-the-counter market after repaying general investors’ claims as per the commission’s exit plan directive. New Age photo
The Bangladesh Securities and Exchange Commission has moved to delist eight more companies trading on the over-the-counter market after repaying general investors’ claims as per the commission’s exit plan directive.
Uncertainty over Serum vaccine supply to Bangladesh grows
Govt yet to receive 50 lakh doses from Serum scheduled for March
Manzur H Maswood | Published: 23:30, Apr 01,2021 | Updated: 23:55, Apr 01,2021
Uncertainty over the COVID-19 vaccine supply to Bangladesh by Serum Institute of India has increased as the Indian manufacturer failed to supply the committed 50 lakh doses of the Oxford-AstraZeneca-developed vaccine in March.
Serum has also kept Bangladesh authorities in dark about when and how many doses of the vaccine it will send in the next consignment although the country has a shortage of vaccine doses to continue its vaccination programme, including the beginning of the second dose administration on April 8.